IPOBoutique.Com rates secondary offerings to hit the tape with a ‘BUY’, ‘NEUTRAL’ or ‘AVOID’ rating. Senior Managing Partner Scott Sweet maintains a track record for all secondary’s he’s issued with a ‘BUY’ rating.
Company: Aldeyra Therapeutics Inc.
Symbol: ALDX
Price: Last trade $4.75
Description: Re-offer $4.50
Trade Date: 2/14
Shares: 2.2 million
Underwriter(s)Stifel, Canaccord Genuity, Laidlaw & Co.
Rating=Subscription Needed
Company: Gevo, Inc.
Symbol: GEVO
Price: Last trade $2.33
Description: No re-offer range available
Trade Date: 2/14
Shares: 4.3 million
Underwriter(s)Oppenheimer & Co.
Co Manager(s)Rodman & Renshaw
Rating=Subscription Needed